Periodic Reporting for period 1 - BLUES (Bioprocesses for metabolite production from marine invertebrate cell lines)
Reporting period: 2024-01-01 to 2025-06-30
The ultimate goal is to design a pathway for industrial bioprocessing using these invertebrate cell lines as a foundation for producing unique, high-value marine compounds. These novel bioprocesses not only resolve the bottleneck of stock production but also contribute to a more sustainable, circular economy. The technology developed within the project will enable the production of valuable marine natural products through bioprocesses, thereby contributing to the blue bioeconomy.
• Assessing the proliferation rates of 10 sponge species, which produce valuable metabolites, to determine which 2 species to select for the development of immortal cell lines
• Developing a novel photo-bioreactor for the culture of corals with a day and night cycle
• Dissection methodologies for the sea cucumber C. frondosa to isolate and extract cells from specific layers of the body wall
• Optimization of extraction and culture protocols for various sponge, coral, sea cucumber cells and tunicate cells
• Fabrication of 3D scaffolds, three in total, made from marine derived collagen for scale-up of marine invertebrate cultures
• Scale-up of G. cydonium and G. barretti cultures from T25 flasks (~10mL) to 2 x 125mL custom made bioreactors using 3D scaffolds made of marine derived collagen
• Quantification of Frondoside A yields from frozen and dried C. frondosa. Analysis was conducted on both the whole organism and different layers of the body wall. This informed the layer of interest for cell culture
• Quantification of Stevensine yields from frozen and dried A. corrugata
• Improvement of methods for sponge hybridoma development using both poly-ethylene glycol and electrofusion
We have also tested the use of scaffolds - made of natural marine-based components such as collagen from fish skin – for the ability to support the attachment and growth of marine sponge cells G. cydonium and G. barretti in a bioreactor of 125mL. This is the first and largest bioreactor cultivation of marine-sponge cells in history, making this a groundbreaking achievement. Given that this achievement has come so early in the project, we aim to build upon this success and further improve the cell culture via media optimisation, scaffold optimisation and increasing and improving the bioreactor scale and functionality.
The first two needs to ensure uptake - further research and demonstration - are the main ones being targeted. There is potential to leverage IPR support, which is being investigated further by the consortium leader, Wageningen University, as the project develops and produces patentable outcomes. It is currently too early in the project to predict what additional measure will be necessary, but this will be monitored throughout the course of the project.